| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 132.63K | — |
| Operating expense | — | — |
| Net income | -1.03M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TTX.F returned -11.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +23.9% |
| 1 year | -11.4% |
| 5 years | -9.9% |
| All-time high | €0.31 (Mar 2022) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in TTX.F would be worth today ›No. Theralase Technologies Inc. has not paid a dividend in the past 12 months.
Theralase Technologies Inc. is part of the Healthcare sector.
Theralase Technologies Inc. has a market cap of 32.23M EUR, based on the latest quote.
Theralase Technologies Inc. is expected to report earnings around Aug 26, 2026. That date is an estimate and has not been confirmed by the company.
